The approved investment aims to create jobs, expand the capacity of the Indian company through investments in plant and equipment, and enhance its operational efficiency. The partnership with Advent Group is expected to provide a broader platform for M/s Suven Pharmaceuticals Limited, fostering business expansion, operational excellence, increased productivity, and adherence to global management best practices. It will also offer training opportunities to professionals and elevate environmental, health, and safety standards.